Clinical Trial Update: Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing Ustekinumab, Infliximab, and their combination in moderately to severely active Ulcerative Colitis; the study is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Infliximab (infliximab)
• USTEKINUMAB (USTEKINUMAB)

Snippet

Sponsor: Medical University of Lodz | Conditions: Ulcerative Colitis, Inflammatory Bowel Diseases | Phase 2 | Status: RECRUITING